Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Incentives
NCT07755748 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2026-08-10
Summary
This is a randomized trial to assess whether offering a financial incentive will improve the response rate to a telephone survey. Three incentive approaches will be compared: a $5 gift card, entry into a monthly $100 drawing, or no incentive.
Conditions
- Screening
Interventions
- OTHER
-
$5 gift card
A $5 gift card is offered as an incentive to participation in the 3-month survey call.
- OTHER
-
$100 monthly drawing
Entry into monthly drawing for $100 gift card is offered as an incentive to participation in the 3-month survey call.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Jeremy D Keenan, MD MPH · University of California, San Francisco
-
Yvonne Ou, MD · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2027-08-01
- Completion
- 2028-08-01
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
NCT02852057 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT03293992 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT02136940 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT07495852 ·Status: RECRUITING ·Phase: PHASE3
-
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
NCT00329095 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04445519 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
NCT03310580 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
NCT01719809 ·Status: TERMINATED
-
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT07075718 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
NCT05583474 ·Status: COMPLETED ·Phase: PHASE3
-
Glaucoma Screening
NCT06186388 ·Status: COMPLETED ·Phase: NA
-
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
NCT01520116 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)
NCT04737928 ·Status: COMPLETED ·Phase: NA
-
Survey of Patients Taking IOP-Lowering Eye Drops
NCT02384772 ·Status: COMPLETED
-
A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure
NCT05451329 ·Status: COMPLETED ·Phase: PHASE2
-
Glaucoma Biomarkers
NCT01677507 ·Status: COMPLETED ·Phase: PHASE4
-
Adherence Improvement in Glaucoma Patients
NCT00603005 ·Status: COMPLETED ·Phase: NA
-
Effects of Anti-Glaucoma Medications on the Ocular Surface
NCT01315574 ·Status: TERMINATED ·Phase: PHASE4
-
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284 ·Status: TERMINATED ·Phase: PHASE3
-
Ocular Hypotensive Efficacy of AR-102
NCT00523250 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT03762369 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
NCT00868894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
NCT00753168 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Methazolamide to Lower Intraocular Pressure
NCT05498103 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4